Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>I tally 42 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.</li>
<li>Two new deals discussed this week: <a href="https://www.smartkarma.com/entities/get-nice-financial-group-ltd" target="_blank" data-smartkarma-citation="entities:29667:1" rel="noopener">Get Nice Financial Group Ltd (1469 HK)</a>'s scrip Offer, and <a href="https://www.smartkarma.com/entities/net-one-systems-co-ltd" target="_blank" data-smartkarma-citation="entities:1279:1" rel="noopener">Net One Systems (7518 JP)</a>'s tender Offer. Plus <a href="https://www.smartkarma.com/entities/sigma-healthcare-ltd" target="_blank" data-smartkarma-citation="entities:15966:1" rel="noopener">Sigma Healthcare (SIG AU)</a>'s reverse takeover.</li>
<li>Key updates took place on: <a href="https://www.smartkarma.com/entities/latin-resources-ltd" target="_blank" data-smartkarma-citation="entities:8770:1" rel="noopener">Latin Resources (LRS AU)</a>, <a href="https://www.smartkarma.com/entities/i-rom-group-co-ltd" target="_blank" data-smartkarma-citation="entities:2686:1" rel="noopener">I'Rom Group (2372 JP)</a>, <a href="https://www.smartkarma.com/entities/malaysia-airports-holdings-bhd" target="_blank" data-smartkarma-citation="entities:117:1" rel="noopener">Malaysia Airports Holdings (MAHB MK)</a>, <a href="https://www.smartkarma.com/entities/korea-zinc-co-ltd" target="_blank" data-smartkarma-citation="entities:17944:1" rel="noopener">Korea Zinc (010130 KS)</a>, and <a href="https://www.smartkarma.com/entities/propertyguru-group-limited" target="_blank" data-smartkarma-citation="entities:28149:1" rel="noopener">PropertyGuru (PGRU US)</a>.</li>
</ul>


I tally 42 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.
Two new deals discussed this week: Get Nice Financial Group Ltd (1469 HK)'s scrip Offer, and Net One Systems (7518 JP)'s tender Offer. Plus Sigma Healthcare (SIG AU)'s reverse takeover.
Key updates took place on: Latin Resources (LRS AU), I'Rom Group (2372 JP), Malaysia Airports Holdings (MAHB MK), Korea Zinc (010130 KS), and PropertyGuru (PGRU US).


(Mostly) Asia-Pac M&A: Sigma Healthcare, Get Nice, Net One Systems, Latin Resources, Korea Zinc

Travis Lundy

<ul>
<li>A Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-06/seven-i-is-said-to-plan-reducing-stake-in-banking-unit-to-38" target="_blank" rel="noopener">article</a> yesterday suggested <a href="https://www.smartkarma.com/entities/seven-i-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:1041:1" rel="noopener">Seven &amp; I Holdings (3382 JP)</a> was considering selling down its stake in <a href="https://www.smartkarma.com/entities/seven-bank-ltd" target="_blank" data-smartkarma-citation="entities:16063:1" rel="noopener">Seven Bank Ltd (8410 JP)</a> to 38%, potentially raising ¥30bn by end-February.</li>
<li>There is a clear and obvious reason for this which has nothing to do, directly, with the Couche-Tard approach. And nothing to do with raising ¥30bn. </li>
<li>But it is an important step on the path to "value realisation", and focussing on CVS, albeit for technical reasons.</li>
</ul>


A Bloomberg article yesterday suggested Seven &amp; I Holdings (3382 JP) was considering selling down its stake in Seven Bank Ltd (8410 JP) to 38%, potentially raising ¥30bn by end-February.
There is a clear and obvious reason for this which has nothing to do, directly, with the Couche-Tard approach. And nothing to do with raising ¥30bn. 
But it is an important step on the path to "value realisation", and focussing on CVS, albeit for technical reasons.


7&I (3382) Selldown of Seven Bank (8410) Is Good, Not Bad

<ul>
<li>H1 sales were GOOD. H1 earnings were BAD. New forecasts are UGLY. The CVS initiatives are RESPECTABLE, but US CVS market environment UNFORTUNATE. The creation of the new Holdco ENCOURAGING.</li>
<li>The Couche-Tard Bid? That's SEPARATE. Confidential. But three weeks after receiving the new proposal, it hasn't been publicly rejected. So that's a thing. </li>
<li>7&amp;i is progressing with its Standalone Plan, as it should, because ACT's bid is more a show of faith for discussions. The York Holdings structure is INTERESTING.</li>
</ul>


H1 sales were GOOD. H1 earnings were BAD. New forecasts are UGLY. The CVS initiatives are RESPECTABLE, but US CVS market environment UNFORTUNATE. The creation of the new Holdco ENCOURAGING.
The Couche-Tard Bid? That's SEPARATE. Confidential. But three weeks after receiving the new proposal, it hasn't been publicly rejected. So that's a thing. 
7&amp;i is progressing with its Standalone Plan, as it should, because ACT's bid is more a show of faith for discussions. The York Holdings structure is INTERESTING.


7&I Results and Plans - The Good, The Bad, The Ugly, The Respectable, Unfortunate, and Encouraging

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>In response to media reports, <a href="https://www.smartkarma.com/entities/seven-i-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:1041:1" rel="noopener">Seven &amp; I Holdings (3382 JP)</a> confirmed receiving a revised non-binding proposal from <a href="https://www.smartkarma.com/entities/alimentation-couche-tard-inc" target="_blank" data-smartkarma-citation="entities:25103:1" rel="noopener">Alimentation Couche-Tard (ATD CN)</a>. </li>
<li>The rumoured revised offer is US$18.19, a 22.4% premium to the initial US$14.86 offer. The revised terms are attractive vs precedent transactions and analyst price targets.</li>
<li>The Board would cite regulatory concerns and the revised offer's implied discount compared to peer multiples. At tomorrow's results, the Board must present a credible alternative value generation path.</li>
</ul>


In response to media reports, Seven &amp; I Holdings (3382 JP) confirmed receiving a revised non-binding proposal from Alimentation Couche-Tard (ATD CN). 
The rumoured revised offer is US$18.19, a 22.4% premium to the initial US$14.86 offer. The revised terms are attractive vs precedent transactions and analyst price targets.
The Board would cite regulatory concerns and the revised offer's implied discount compared to peer multiples. At tomorrow's results, the Board must present a credible alternative value generation path.


Seven & I Holdings (3382 JP): Pressure Mounts with a Couche-Tard Revised Offer

<ul>
<li>
<a href="https://www.smartkarma.com/entities/seven-i-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:1041:1" rel="noopener">Seven &amp; I Holdings (3382 JP)</a> is currently "in limbo" as the initial <a href="https://www.smartkarma.com/entities/alimentation-couche-tard-inc" target="_blank" data-smartkarma-citation="entities:25103:1" rel="noopener">Alimentation Couche-Tard (ATD CN)</a> ("ACT") has been rejected, some news is out, and we await earnings/presentations.</li>
<li>The news last week was that 7&amp;i might sell down a stake in <a href="https://www.smartkarma.com/entities/seven-bank-ltd" target="_blank" data-smartkarma-citation="entities:16063:1" rel="noopener">Seven Bank Ltd (8410 JP)</a> and could sell its retail/superstore business to PE rather than an IPO.</li>
<li>Both selldowns mean the focus on CVS everyone seems to want. That's good news. And the shares are trading at/below ACT terms which "grossly undervalued" the company. Bullish. </li>
</ul>



Seven &amp; I Holdings (3382 JP) is currently "in limbo" as the initial Alimentation Couche-Tard (ATD CN) ("ACT") has been rejected, some news is out, and we await earnings/presentations.
The news last week was that 7&amp;i might sell down a stake in Seven Bank Ltd (8410 JP) and could sell its retail/superstore business to PE rather than an IPO.
Both selldowns mean the focus on CVS everyone seems to want. That's good news. And the shares are trading at/below ACT terms which "grossly undervalued" the company. Bullish. 


7&I (3382) - Asset Sale News Designed to Get Shareholder Attention to Future Value

Japan

Seven Bank, Ltd. provides banking services mainly through Automated Teller Machine (ATM) across Japan. The bank cooperates with affiliated financial institutions to establish the nationwide ATM network and provide remote banking services, including deposits and loans.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Seven Bank Ltd (8410 JP)

(Mostly) Asia-Pac M&A: Sigma Healthcare, Get Nice, Net One Systems, Latin Resources, Korea Zinc

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

7&I (3382) Selldown of Seven Bank (8410) Is Good, Not Bad

Today, an article suggested 7&i would sell a stake in Seven Bank. This is good news for 7&i. It is not bad news for Seven Bank. It has abundant...

Travis Lundy

7&I Results and Plans - The Good, The Bad, The Ugly, The Respectable, Unfortunate, and Encouraging

Seven and I today announced results, new lower forecasts, plans to spin out almost all the retail businesses into an Intermediate Holdco (w/...

Travis Lundy

Seven & I Holdings (3382 JP): Pressure Mounts with a Couche-Tard Revised Offer

The revised offer will mount pressure to engage. The Board is running out of excuses and will lean heavily on an alternative value generation path...

Arun George

7&I (3382) - Asset Sale News Designed to Get Shareholder Attention to Future Value

7&i reports earnings this week. Shareholders will want info on ACT, or why "intrinsic value" is higher. It's an easy explanation, but new news on...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)